发布求助
文献互助 智能选刊 最新文献

Epidemiology and Treatment of Atrial Fibrillation最新文献

筛选
英文 中文
Surgical Treatment of Atrial Fibrillation 房颤的外科治疗
Epidemiology and Treatment of Atrial Fibrillation Pub Date : 2020-02-27 DOI: 10.5772/intechopen.91225
M. Navaratnarajah, S. Luthra, S. Ohri
{"title":"Surgical Treatment of Atrial Fibrillation","authors":"M. Navaratnarajah, S. Luthra, S. Ohri","doi":"10.5772/intechopen.91225","DOIUrl":"https://doi.org/10.5772/intechopen.91225","url":null,"abstract":"The concepts, techniques and evidence relating to surgical ablation of atrial fibrillation are discussed in detail. The historical background to surgical ablation is covered in brief, along with the electrophysiological basis underpinning its effective useage. The epidemiology of surgically treated atrial fibrillation and the current guidelines relating to its use are analysed. Safety aspects and perspectives on its ongoing future use are discussed. Modern surgical technologies and approaches are reviewed, along with the relevant advantages and disadvantages of each. The surgical techniques relating to left atrial appendage intervention are also reviewed, along with the relevant literature and evidence relating to reduction in thromboembolic risk and need for anticoagulation.","PeriodicalId":310464,"journal":{"name":"Epidemiology and Treatment of Atrial Fibrillation","volume":"73 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123454275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulation in AF and Elderly Frail Patient: How to Face New Challenges 房颤和老年体弱患者抗凝治疗:如何面对新的挑战
Epidemiology and Treatment of Atrial Fibrillation Pub Date : 2019-09-27 DOI: 10.5772/intechopen.88723
Alba Mª Costa Grille, I. Martín, R. P. Torregrossa
{"title":"Anticoagulation in AF and Elderly Frail Patient: How to Face New Challenges","authors":"Alba Mª Costa Grille, I. Martín, R. P. Torregrossa","doi":"10.5772/intechopen.88723","DOIUrl":"https://doi.org/10.5772/intechopen.88723","url":null,"abstract":"Aging is an important risk factor for patients with atrial fibrillation. The estimated prevalence of atrial fibrillation in patients aged ≥ 80 years is 9–10%, with four- to fivefold increased risk of embolic stroke and with an estimated increased stroke risk of 1.45-fold per decade in aging. Older age is also associated with increased risk of major bleeding with oral anticoagulant (OAC) therapy. In this chapter, we will focus on the role of oral anticoagulation with new oral anticoagulants, non-vitamin K antagonist, in populations with common comorbid conditions, including age; chronic kidney disease; coronary artery disease, on multiple medication; and frailty. In patients 75 years and older, randomized trials have shown new oral anticoagulants to be as effective as warfarin, or in some cases superior, with an overall better safety profile, consistently reducing rates of intracranial hemorrhages. Prior to considering oral anticoagulant therapy in an elderly frail patient, a comprehensive assessment should be performed to include the risk and benefits, stroke risk, baseline kidney function, cognitive status, mobility and falling risk, multiple medication, nutritional status assessment, and life expectancy.","PeriodicalId":310464,"journal":{"name":"Epidemiology and Treatment of Atrial Fibrillation","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121671381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Anticoagulation in Atrial Fibrillation Patients 房颤患者的抗凝治疗
Epidemiology and Treatment of Atrial Fibrillation Pub Date : 2019-09-27 DOI: 10.5772/intechopen.88965
P. Magnusson, J. Pergolizzi, Randall K. Wolf, M. Lamberts, J. LeQuang
{"title":"Anticoagulation in Atrial Fibrillation Patients","authors":"P. Magnusson, J. Pergolizzi, Randall K. Wolf, M. Lamberts, J. LeQuang","doi":"10.5772/intechopen.88965","DOIUrl":"https://doi.org/10.5772/intechopen.88965","url":null,"abstract":"Atrial fibrillation (AF) is the most common arrhythmia and may cause thromboembolic events, typically stroke. Advances in pharmacological approaches to anticoagulation and groundbreaking large randomized controlled trials of non-vitamin K antagonist oral anticoagulants (NOACs) have changed the paradigm of anticoagulation therapy. Furthermore, observational studies support the efficacy and safety of NOAC. Few studies address the differences among NOACs, but prescriptions should be based on a thorough understanding of their pharmacological differences, including interactions, side effects, reversibility, and practical approach. In a subset of patients with AF, warfarin may still be the preferable option. Consequently, an individualized approach to oral anticoagulation is crucial.","PeriodicalId":310464,"journal":{"name":"Epidemiology and Treatment of Atrial Fibrillation","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126357096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
New Results in Catheter Ablation for Atrial Fibrillation 房颤导管消融治疗的新结果
Epidemiology and Treatment of Atrial Fibrillation Pub Date : 2019-08-08 DOI: 10.5772/INTECHOPEN.88468
N. Szegedi, L. Gellér
{"title":"New Results in Catheter Ablation for Atrial Fibrillation","authors":"N. Szegedi, L. Gellér","doi":"10.5772/INTECHOPEN.88468","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.88468","url":null,"abstract":"Pulmonary vein isolation (PVI) is the cornerstone of rhythm-control therapy for atrial fibrillation (AF). A few years ago, contact force-sensing ablation catheters (CFSAC) were introduced. Nowadays the use of CFSAC became a part of the everyday practice. The durability of PVI depends much on the accurate lesion creation. The recently developed techniques (ablation index, CLOSE protocol) may facilitate the procedure in terms of achieving durable PVI which has already been confirmed by randomized trials. In this chapter, we would like to introduce the theoretical background of PVI and compare different techniques (radiofrequency point-by-point, cryoballoon, additional ablation lines for persistent AF) with special highlight on the importance of durable PVI.","PeriodicalId":310464,"journal":{"name":"Epidemiology and Treatment of Atrial Fibrillation","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129290963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Screening for Atrial Fibrillation and the Role of Digital Health Technologies 房颤筛查和数字健康技术的作用
Epidemiology and Treatment of Atrial Fibrillation Pub Date : 2019-08-07 DOI: 10.5772/INTECHOPEN.88660
Edward Richardson, A. Hall, A. Mitchell
{"title":"Screening for Atrial Fibrillation and the Role of Digital Health Technologies","authors":"Edward Richardson, A. Hall, A. Mitchell","doi":"10.5772/INTECHOPEN.88660","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.88660","url":null,"abstract":"Atrial fibrillation is the commonest clinical arrhythmia and a leading cause of hospital admission, morbidity and mortality. New digital health technologies are now allowing patients and the general population to identify heart rhythm abnor-malities before any encounter with a medical professional. This chapter will include an overview of the prevalence of atrial fibrillation and explore the current recommendations on methods for arrhythmia screening. We discuss different risk factors as well as physiological and structural markers for atrial fibrillation onset. We explore in detail the application of novel digital health technologies such as wearables, watches and mobile devices which may have an impact on screening detection rates. The article concludes with a discussion about how to manage patients with screen detected atrial fibrillation.","PeriodicalId":310464,"journal":{"name":"Epidemiology and Treatment of Atrial Fibrillation","volume":"200 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123374626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信